SMARCB1 and hemoglobinopathy: Recently, extremely atypical and uncommon tumors that share morphological and phenotypic characteristics with RMC, but occur in patients without hemoglobinopathy, have been reported and temporarily termed “unclassified RCC with medullary phenotype and SMARCB1 deficiency” (4).